Free Trial

Tandem Diabetes Care (TNDM) Competitors

Tandem Diabetes Care logo
$21.65 -1.87 (-7.95%)
Closing price 04:00 PM Eastern
Extended Trading
$23.04 +1.39 (+6.42%)
As of 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

TNDM vs. GKOS, NARI, INSP, IRTC, BLCO, TMDX, SLNO, NVST, PRCT, and LIVN

Should you be buying Tandem Diabetes Care stock or one of its competitors? The main competitors of Tandem Diabetes Care include Glaukos (GKOS), Inari Medical (NARI), Inspire Medical Systems (INSP), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Envista (NVST), PROCEPT BioRobotics (PRCT), and LivaNova (LIVN). These companies are all part of the "medical equipment" industry.

Tandem Diabetes Care vs.

Glaukos (NYSE:GKOS) and Tandem Diabetes Care (NASDAQ:TNDM) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their community ranking, earnings, profitability, institutional ownership, analyst recommendations, valuation, dividends, media sentiment and risk.

Tandem Diabetes Care has a net margin of -14.84% compared to Glaukos' net margin of -39.04%. Glaukos' return on equity of -16.53% beat Tandem Diabetes Care's return on equity.

Company Net Margins Return on Equity Return on Assets
Glaukos-39.04% -16.53% -10.61%
Tandem Diabetes Care -14.84%-44.19%-11.99%

99.0% of Glaukos shares are held by institutional investors. 5.8% of Glaukos shares are held by company insiders. Comparatively, 1.9% of Tandem Diabetes Care shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Tandem Diabetes Care received 133 more outperform votes than Glaukos when rated by MarketBeat users. However, 65.19% of users gave Glaukos an outperform vote while only 60.89% of users gave Tandem Diabetes Care an outperform vote.

CompanyUnderperformOutperform
GlaukosOutperform Votes
457
65.19%
Underperform Votes
244
34.81%
Tandem Diabetes CareOutperform Votes
590
60.89%
Underperform Votes
379
39.11%

Glaukos has higher earnings, but lower revenue than Tandem Diabetes Care. Glaukos is trading at a lower price-to-earnings ratio than Tandem Diabetes Care, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Glaukos$404.52M13.42-$134.66M-$2.37-40.08
Tandem Diabetes Care$982.95M1.47-$222.61M-$2.78-7.79

In the previous week, Glaukos had 1 more articles in the media than Tandem Diabetes Care. MarketBeat recorded 10 mentions for Glaukos and 9 mentions for Tandem Diabetes Care. Tandem Diabetes Care's average media sentiment score of 1.72 beat Glaukos' score of 1.43 indicating that Tandem Diabetes Care is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Glaukos
9 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Tandem Diabetes Care
8 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Glaukos presently has a consensus price target of $134.67, suggesting a potential upside of 41.78%. Tandem Diabetes Care has a consensus price target of $39.81, suggesting a potential upside of 83.89%. Given Tandem Diabetes Care's higher possible upside, analysts plainly believe Tandem Diabetes Care is more favorable than Glaukos.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Glaukos
1 Sell rating(s)
1 Hold rating(s)
10 Buy rating(s)
0 Strong Buy rating(s)
2.75
Tandem Diabetes Care
0 Sell rating(s)
8 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.53

Glaukos has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500. Comparatively, Tandem Diabetes Care has a beta of 1.47, meaning that its share price is 47% more volatile than the S&P 500.

Summary

Glaukos beats Tandem Diabetes Care on 11 of the 18 factors compared between the two stocks.

Get Tandem Diabetes Care News Delivered to You Automatically

Sign up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TNDM vs. The Competition

MetricTandem Diabetes CareSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1.44B$4.49B$5.37B$8.38B
Dividend YieldN/A43.63%5.22%4.11%
P/E Ratio-11.2229.4326.8419.71
Price / Sales1.4767.72392.34117.39
Price / CashN/A51.0838.2534.62
Price / Book4.506.236.794.50
Net Income-$222.61M$68.16M$3.23B$248.18M
7 Day Performance-5.25%18.33%4.07%1.14%
1 Month Performance32.09%23.04%12.52%15.20%
1 Year Performance-56.10%20.61%16.83%6.56%

Tandem Diabetes Care Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TNDM
Tandem Diabetes Care
4.5167 of 5 stars
$21.65
-8.0%
$39.81
+83.9%
-50.2%$1.44B$982.95M-11.222,600Positive News
Gap Up
GKOS
Glaukos
4.6206 of 5 stars
$94.57
+5.1%
$134.67
+42.4%
-10.7%$5.40B$404.52M-32.95780News Coverage
Positive News
NARI
Inari Medical
0.5708 of 5 stars
$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800News Coverage
INSP
Inspire Medical Systems
4.6758 of 5 stars
$156.54
+3.5%
$211.91
+35.4%
-3.4%$4.62B$840.11M90.49760Positive News
IRTC
iRhythm Technologies
1.2686 of 5 stars
$137.80
+0.1%
$128.55
-6.7%
+52.5%$4.40B$618.59M-37.861,790Positive News
BLCO
Bausch + Lomb
4.2513 of 5 stars
$11.91
+5.6%
$15.50
+30.2%
-19.2%$4.21B$4.83B-13.0812,500Gap Up
TMDX
TransMedics Group
1.4381 of 5 stars
$118.73
+6.5%
$126.70
+6.7%
-10.0%$4.02B$488.23M126.31210Positive News
SLNO
Soleno Therapeutics
4.8514 of 5 stars
$76.70
-0.1%
$106.78
+39.2%
+59.6%$3.87BN/A-23.1030News Coverage
Positive News
NVST
Envista
4.1752 of 5 stars
$18.56
+5.5%
$20.08
+8.2%
-2.7%$3.15B$2.50B-2.8612,700Positive News
Gap Up
PRCT
PROCEPT BioRobotics
2.9275 of 5 stars
$54.44
+2.5%
$90.00
+65.3%
-13.9%$3.01B$249.12M-27.92430Positive News
Gap Up
LIVN
LivaNova
3.8004 of 5 stars
$45.23
+2.7%
$59.17
+30.8%
-26.8%$2.47B$1.28B107.692,900Analyst Upgrade
Gap Up
High Trading Volume

Related Companies and Tools


This page (NASDAQ:TNDM) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners